Stevens-Johnson syndrome due to carbamazepine.

dc.contributor.authorDuggal, H Sen_US
dc.contributor.authorKhess, C Ren_US
dc.date.accessioned2001-05-22en_US
dc.date.accessioned2009-05-31T01:57:49Z
dc.date.available2001-05-22en_US
dc.date.available2009-05-31T01:57:49Z
dc.date.issued2001-05-22en_US
dc.identifier.citationDuggal HS, Khess CR. Stevens-Johnson syndrome due to carbamazepine. Journal of the Association of Physicians of India. 2001 May; 49(): 591-2en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/92628
dc.language.isoengen_US
dc.source.urihttps://www.japi.orgen_US
dc.subject.meshAntimanic Agents --adverse effectsen_US
dc.subject.meshCarbamazepine --adverse effectsen_US
dc.subject.meshHumansen_US
dc.subject.meshStevens-Johnson Syndrome --chemically induceden_US
dc.subject.meshTreatment Outcomeen_US
dc.titleStevens-Johnson syndrome due to carbamazepine.en_US
dc.typeCase Reportsen_US
dc.typeCommenten_US
dc.typeLetteren_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: